{"nct_id":"NCT02476006","title":"Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)","status":"COMPLETED","status_verified_date":"2022-03","start_date":"2015-06-23","start_date_type":"ACTUAL","primary_completion_date":"2019-04-12","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}